Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents
US11420970B1 · kind B1 · utility
1Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2021 |
| Grant date | Aug 23, 2022 |
| Priority date | — |
| Expiry date | May 21, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a compound of Formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.